Data on this page show the responses of individuals who received a Shingrix® vaccine and completed an AusVaxSafety survey sent on day 3 after vaccination. These data give a profile of what to expect in the days following Shingrix® vaccination and can assist when planning for your Shingrix® vaccination. Data on this page are updated monthly. 

AusVaxSafety's active vaccine safety surveillance system complements the enhanced safety surveillance activities of the Therapeutic Goods Administration (TGA). Find out more about how the TGA monitors the safety of vaccines and how you can report side effects on the TGA website.

Last updated April 2024